CURE’s lymphoma cancer page is a go-to resource for oncology news and updates in the world of lymphoma cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in lymphoma cancer.
November 18th 2024
As a four-time cancer survivor, I can tell you that survivorship means many things to each survivor.
September 23rd 2024
Patients Need Facts About Rare Cancers, Like Lymphoma Associated With Breast Implants
August 29th 2019Knowledge is essential for any patient facing cancer, and this issue provides the facts not only about breast implant-associated anaplastic large cell lymphoma but also other rare cancer types or mutations.
Medicare Coverage of CAR-T Cell Therapy Opens Patient Access to Life-Saving Treatment
August 17th 2019Following its announcement of covering chimeric antigen receptor-T cell therapy nationwide, the Centers for Medicare and Medicaid Services has now made this highly-priced, but life-saving, treatment available to many who would not otherwise have access to it at their cancer centers.
FDA Asks Allergan to Voluntarily Recall Breast Implants to Protect Against Rare Cancer
July 24th 2019The Food and Drug Administration has requested that the manufacturer voluntarily recall certain breast implants and tissue expanders from the market to protect women from risks such as breast implant-associated anaplastic large cell lymphoma.
FDA Approves Biosimilar Ruxience: Here's What You Need to Know
July 24th 2019With the Food and Drug Administration’s approval of Ruxience, a biosimilar to Rituxan, patients with certain types of non-Hodgkin lymphoma and chronic lymphocytic leukemia may have improved access to a more affordable treatment option.
Breast Implant-Associated Lymphoma: Do I Need to be Concerned?
June 27th 2019Women who undergo a mastectomy have many options and concerns to consider when undergoing breast reconstruction. My choice was simple: I wanted to look as natural as possible, but I have since learned that I have textured implants.
FDA Grants Polivy Accelerated Approval for DLBCL
June 10th 2019The FDA has granted an accelerated approval to Polivy for use in combination with bendamustine and Rituxan for the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma who have received at least two prior therapies.
Survey Shows Split Between Blood Cancer Detection: Symptom Evaluation vs. Incidental Finding
April 30th 2019Only half of patients reported their blood cancer was detected while visiting a doctor after experiencing symptoms versus detection during a routine medical test or exam or while under the care of a doctor for another health condition.